Oppenheimer & Co. Inc. Buys 11,145 Shares of PACS Group, Inc. $PACS

Oppenheimer & Co. Inc. bought a new stake in PACS Group, Inc. (NYSE:PACS) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 11,145 shares of the company’s stock, valued at approximately $463,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP grew its position in PACS Group by 370.2% during the first quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock valued at $25,051,000 after acquiring an additional 614,250 shares during the period. Bank of New York Mellon Corp acquired a new stake in PACS Group during the second quarter worth about $8,196,000. Principal Financial Group Inc. purchased a new position in shares of PACS Group in the 1st quarter worth about $3,171,000. Arrowstreet Capital Limited Partnership raised its holdings in shares of PACS Group by 44.6% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock worth $9,274,000 after purchasing an additional 89,067 shares during the period. Finally, Cantor Fitzgerald Investment Advisors L.P. acquired a new position in shares of PACS Group in the 3rd quarter valued at about $1,920,000.

More PACS Group News

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: Third-quarter EPS of $0.63 topped estimates of $0.58, while revenue of $1.50 billion exceeded the $1.46 billion consensus. Adjusted EBITDA reportedly rose 33.6%, reinforcing evidence of operating growth. PACS Group, Inc. Reports Third Quarter 2026 Results PACS Group Q3 2026: EBITDA Surges 33.6%
• Positive Sentiment: PACS raised its 2026 revenue outlook to $5.95 billion–$6.05 billion and adjusted EBITDA guidance to $685 million–$695 million. The company also highlighted acquisitions in Florida and Texas and facility occupancy around 90%, supporting its expansion story. PACS raises 2026 outlook PACS acquisitions and Q3 results
• Positive Sentiment: Truist reaffirmed its Buy rating and raised its target to $65 from $62; Stephens raised its target to $64 from $60 and assigned an Overweight rating. Higher targets signal continued analyst confidence in potential upside. Truist analyst ratings Stephens analyst ratings
• Negative Sentiment: The CEO, a director, and the chief accounting officer reported share sales. These could weigh slightly on sentiment, but the trades were made under pre-arranged Rule 10b5-1 plans, and the CEO and director retained large holdings. PACS insider transactions

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. JPMorgan Chase & Co. boosted their target price on PACS Group from $47.00 to $58.00 and gave the stock an “overweight” rating in a report on Friday, September 4th. Wall Street Zen downgraded shares of PACS Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 8th. Truist Financial restated a “buy” rating and issued a $65.00 price target (up from $62.00) on shares of PACS Group in a report on Thursday. Zacks Research cut shares of PACS Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 9th. Finally, Oppenheimer lifted their price target on shares of PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a research report on Monday, August 10th. Six equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $61.33.

Insider Activity at PACS Group

In other news, CAO Michelle Lewis sold 3,172 shares of PACS Group stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $50.06, for a total transaction of $158,790.32. Following the sale, the chief accounting officer owned 340,338 shares in the company, valued at $17,037,320.28. This trade represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jason Murray sold 167,434 shares of PACS Group stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $50.24, for a total transaction of $8,411,884.16. Following the sale, the chief executive officer owned 53,954,101 shares in the company, valued at $2,710,654,034.24. This represents a 0.31% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 1,762,431 shares of company stock worth $80,686,053. 70.10% of the stock is currently owned by company insiders.

PACS Group Trading Down 0.5%

Shares of PACS opened at $50.03 on Friday. The stock’s 50-day moving average is $44.53 and its two-hundred day moving average is $39.96. The stock has a market cap of $7.94 billion, a PE ratio of 22.95, a P/E/G ratio of 1.57 and a beta of -0.14. PACS Group, Inc. has a 12 month low of $10.31 and a 12 month high of $51.68. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.80 and a quick ratio of 0.91.

PACS Group (NYSE:PACS) last issued its earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.58 by $0.05. PACS Group had a return on equity of 31.98% and a net margin of 4.87%. The company had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.46 billion. Equities analysts forecast that PACS Group, Inc. will post 2.13 earnings per share for the current fiscal year.

PACS Group Company Profile

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.